Results 161 to 170 of about 532,276 (294)

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

The EMU: forerunners and durability [PDF]

The first article examines the history and theory of monetary unions to ask what factors will foster a stable European Monetary Union. It concludes that a decentralized arrangement of national central banks may undermine the EMU’s durability.European ...
Robert F. Graboyes
core  

Beyond one-size-fits-all: leveraging mixed-methods qualitative analysis of local stakeholders to tailor validated prehospital care solutions in the Cameroonian cultural context. [PDF]

BMJ Open
OConnor K, Hayashi A, Tabe V, Dissak-Delon FN, Nsen L, Joel M, Tanue EA, Oke R, Delaney PG, Eisner Z, Chichom Mefire A, Juillard C, Christie AS.   +12 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Fiscal Reform and Monetary Union in West Africa [PDF]

The paper explores the interaction between the proposed monetary union for ECOWAS and structural reforms of fiscal policy. The effects depend to a large extent on the degree of similarity of member countries.
Hefeker, Carsten
core  

Leaving the health workforce during the COVID-19 pandemic: A cross-sectional study among Filipino healthcare workers. [PDF]

PLOS Glob Public Health
Tiu CJS, Alberto NRI, Baron MBC, Mercado MVV, Baticulon RE.   +4 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Inclusiveness of social participation for health reform: findings from a realist review. [PDF]

Int J Equity Health
Mishra S, Chadha N, Esandi ME, Serrao C, Acuña RH, Surendran S, Saini A, Aristegui I, Nambiar D.   +8 more
europepmc   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari, Caroline S. Copeland, Georgia C. Richards   +2 more
wiley   +1 more source

Socio-economic Conditions & Determinants of Income: A Tale of Informal Workers of Urban Odisha, India. [PDF]

F1000Res
Barik S, Mishra NK, Saxena M.
europepmc   +1 more source